Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Allergan Aesthetics Expands Portfolio - Happi
Company News, Financial News

Allergan Aesthetics Expands Portfolio

Acquires Luminera’s full dermal filler portfolio and R&D pipeline.

Allergan Aesthetics, an AbbVie company, has entered into an agreement with Luminera, a privately held, aesthetics company based in Israel with a portfolio and pipeline of dermal filler products.
 
Under the terms of the agreement, Allergan Aesthetics will acquire Luminera’s full dermal filler portfolio and R&D pipeline further enhancing Allergan Aesthetics’ dermal filler portfolio with its JUV DERM collection of fillers.
 
“We welcome the Luminera team as we continue to build our global aesthetics company and a world-class product offering for healthcare professionals and patients around the world,” said Carrie Strom, SVP, AbbVie, and president, Global Allergan Aesthetics.
 
Luminera chairman Dadi Segal, PhD, added, “We believe bringing together key, innovative Luminera assets with the support of Allergan Aesthetics will provide an even brighter future for our people, products and a more expanded offering for our customers. This is a tremendous opportunity to further build, develop and collaborate with a leading global aesthetics company.”
 
Luminera’s key value driver for the future is HArmonyCa, a dermal filler intended for facial soft tissue augmentation comprised of a combination of cross-linked hyaluronic acid (HA) with embedded calcium hydroxyapatite (CaHA) microspheres. The combination of HA and CaHA in a single product is highly differentiated in the dermal filler category. HArmonyCa is currently commercially available in Israel and Brazil.
 
Allergan Aesthetics will continue to develop this product for its International and US markets.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters